Filing Flows › HeartSciences (HSCS) › Q1 FY27
HeartSciences (HSCS) Q1 FY27 earnings results (first quarter fiscal 2027)
10-Q filed Sep 14, 2026
HeartSciences (HSCS) reported revenue of $2K for the first quarter fiscal 2027 (Q1 FY27), +11% from a year earlier.
HeartSciences, Q1 FY27: revenue $2K (+10% year over year), net loss $3.2M, operating cash flow −$1.3M. The chart follows the revenue to costs, profit and cash.
| Q1 FY27 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2K | — | +11% |
| Operating profit | −$2.9M | — | — |
| Net earnings | −$3.2M | — | — |
| Operating cash flow | −$1.3M | — | — |
What changed
Revenue was $2K in Q1 FY27, up 11% year over year.
Gross margin was 63.8%, up 3.8 points from Q1 FY26. Operating costs exceeded revenue by $2.9M, an operating margin of -139956.7%. Operating expenses grew 57% against revenue growth of 11%. The fastest-growing cost line was SG&A (+132%). The quarter ended with a net loss of $3.2M.
Operating cash flow was −$1.3M. Non-cash charges added back $6K of depreciation and $739K of share-based compensation. Working capital and other items added $1.1M.
Questions
What was HeartSciences' revenue in the first quarter fiscal 2027?
HeartSciences (HSCS) reported revenue of $2K for the first quarter fiscal 2027 (Q1 FY27), +11% from a year earlier.
Source: HeartSciences 10-Q on SEC EDGAR.